Ring-style blood pressure bracelet test compared with 24-hour monitoring in people with HFrEF
Official title: Feasibility and Effectiveness of a RING-type Blood Pressure Measurement Device (CART-BP) Compared With 24-Hour Ambulatory Blood Pressure Monitoring Device in Patients With Heart Failure With Reduced Ejection Fraction (RING-HFrEF)
Run by Keimyung University Dongsan Medical Center · NCT07626879 · Data updated 2026-11-12
A ring-type blood pressure device is being tested to see if its 24-hour readings match those from standard ambulatory monitoring in adults with heart failure and reduced ejection fraction.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Keimyung University Dongsan Medical Center Academic / other |
| Drugs / interventions | CART |
| Locations | 1 site (Daegu) |
| Status | Recruiting |
| Started | October 23, 2025 |
| Main results expected | October 22, 2026 |
| Study ends | October 22, 2026 |
| Registry record updated | June 4, 2026 |
| Trial ID | NCT07626879 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 19 years or older with diagnosed HFrEF (LVEF ≤ 40%), able to wear the ring device and participate in 24-hour monitoring.
✕Probably not a fit
Patients with very abnormal office BP or those unable to perform 24-hour monitoring or wear the device may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational, multi-center study in South Korea compares a ring-based BP device that uses photoplethysmography (PPG) to the conventional 24-hour ABPM. Fifty? No, 100 patients will be enrolled to measure BP over a full day and assess agreement with ISO 81060-2:2018 criteria for mean, daytime, and nighttime values. An interim analysis after 40 participants will determine whether to continue to the full enrollment. The study focuses on ensuring accuracy in a population where BP readings can be challenging due to reduced cardiac output and vascular changes.
Why it matters
Potential benefit: If successful, the ring device could offer continuous, comfortable BP monitoring for patients with HFrEF, potentially improving BP management.
How similar studies have gone: Previous BP monitoring work with wearable or ring-based devices has shown variable accuracy; this study tests a specific ring device against standard ABPM in HFrEF.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 19 years (male or female) 2. Diagnosed with heart failure and currently under treatment 3. Left ventricular ejection fraction (LVEF) ≤ 40% confirmed by echocardiography performed within 1 year prior to enrollment 4. Able to undergo both 24-hour ambulatory blood pressure monitoring and ring-type blood pressure measurement 5. Voluntarily provided written informed consent to participate in this clinical study Exclusion Criteria: 1. Office blood pressure: SBP \< 90 mmHg, or DBP \< 50 mmHg, or SBP \> 180 mmHg, or DBP \> 100 mmHg 2. Unable to perform 24-hour ambulatory blood pressure monitoring 3. Unable to wear or use the ring-type blood pressure device 4. Variability in three consecutive resting cuff blood pressure measurements ≥ 20 mmHg (SBP) or ≥ 10 mmHg (DBP) 5. Insufficient valid ABPM readings: \< 25 daytime or \< 12 nighttime measurements per ESH criteria; or \< 25 daytime or \< 12 nighttime valid readings from the ring-type device 6. Pregnant, suspected pregnancy, or breastfeeding 7. Judged by the investigator to be legally or mentally unfit to participate in the clinical study
Where it's running
-
Keimyung University Dongsan Medical Center
Daegu, South Korea Recruiting
Study contacts
- Study coordinator: In-Cheol Kim
- Email: kimic@dsmc.or.kr
- Phone: 82-53-258-4629
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
CART BP Pro-guided management for people with uncontrolled high blood pressure
This project will see if using the wearable CART BP Pro ring to guide treatment helps lower blood pressure more than usual office-based care for adults in Korea whose blood pressure is not controlled.
-
Pulmonary Artery Denervation for a specific type of heart and lung pressure problem
This study tests whether the Enhancor System can safely and effectively help patients with combined pre- and post-capillary pulmonary hypertension due to left heart disease when added to standard therapy.
-
Validating the CART BP ring cuffless blood pressure monitor
This study will test whether the CART BP ring gives blood pressure readings that match the standard cuff method in adults with suspected high or low blood pressure.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.